
UrologyMSK
@UrologyMSK
Followers
3K
Following
397
Media
101
Statuses
701
Official account of the Urology Service at Memorial Sloan Kettering Cancer Center @MSKCancerCenter Pictured: Dr. Willet Whitmore, MSK Chief of Urology 1951–1984
Joined May 2019
Now published in @EurUrolOpen by @UrologyMSK Joel Sheinfeld @RichMatulewicz et al: Pathologic and Oncologic Outcomes of Patients Undergoing Orchiectomy After Chemotherapy for Advanced Testicular Germ Cell Tumors https://t.co/JiBEElS2jH
0
1
2
Now published in @Clin_Chem_ADLM by @UrologyMSK Hans Lilja et al: Toward Improved Prostate Cancer Screening: Insights from the Göteborg-2 Trial https://t.co/gkeOuUX3zW
0
0
2
Now published in @UrolOncol by @UrologyMSK @TouijerKarim @vinlaudonemd et al: Assessment of postoperative practices and discharge recommendations after radical prostatectomy https://t.co/1CibWJp3Cy
0
2
9
Amazing to have Dr. Harry Herr, legend and @NYSAUA historian come give Grand Rounds this morning. Thought-provoking talk and impactful to have someone who has trained so many of our @UroOnc faculty come and meet our current residents. @UrologyMSK
1
4
17
Our very own Dr Herr with several all star alumni following his grand rounds lecture @ColumbiaUrology . He discussed urologic history and how past lessons influence current culture. @JamesJmm23
1
3
29
Now published in @urogoldjournal by @UrologyMSK @BehfarEhdaieMD @vinlaudonemd @easthamja et al: Effect of Age on Robotic-Assisted Radical Prostatectomy Outcomes: A Multi-center Analysis https://t.co/K3rFqnHXAz
0
0
3
Now published in @JAMASurgery by @UrologyMSK Jonathan Coleman, @alvincgoh, @BehfarEhdaieMD, Peter Scardino, @easthamja, @vinlaudonemd, @bca_md et al: Rizedisben in Minimally Invasive Surgery: A Nonrandomized Clinical Trial https://t.co/uV2nKuzvOz
jamanetwork.com
This nonrandomized clinical trial evaluates the use of rizedisben, a novel myelin-binding fluorophore, in minimally invasive surgery.
0
0
3
Now published in @UrologyPractice by @UrologyMSK Jonathan Coleman, @arihakimi, Paul Russo et al: Tumors in Solitary Kidneys Are Not All Equal: Outcomes of Partial Nephrectomy in High-Risk Cases https://t.co/Cetq4guIc7
auajournals.org
Introduction:While partial nephrectomy remains the preferred treatment of tumors in solitary kidneys, there is a broad range of complexity to these cases. This retrospective study refines our...
0
1
6
Now published in @Cancers_MDPI by @UrologyMSK Jonathan Coleman et al: Synergistic Efficacy of WST11-VTP and P-Selectin-Targeted Nanotherapy in a Preclinical Prostate Cancer Model https://t.co/8EQQgK6ecr
0
1
2
Now published in @UrologyPractice by @UrologyMSK Harry Herr: Neoadjuvant Chemotherapy and Partial Cystectomy for Muscle-Invasive Bladder Cancer: 20-Year Bladder-Preserved Survival https://t.co/LmYNaGKVAW
auajournals.org
0
1
1
Now published in @EUplatinum by @UrologyMSK @bbmdmsk et al: Increasing Life Expectancy in Patients with Genitourinary Malignancies: Impact of Treatment Burden on Disease Management and Quality of Life https://t.co/Rc0Vrskcni
0
1
3
Another successful robotic boot camp for our clinical fellows led by @alvincgoh and our amazing APP team!
3
2
35
🥇🥇🥇We are thrilled to announce our number one ranking in Urology for the third straight year! Truly a testament to our amazing team of techs, nurses, APPs and fellows!@MSKCancerCenter
https://t.co/hjTtUoDaKJ
health.usnews.com
Learn which hospitals were ranked best by US News & World Report for urology. Scores factor in patient safety, nurse staffing and more.
0
10
38
Now published in @NEJM by @UrologyMSK Jonathan Coleman et al.: Nonoperative Management of Mismatch Repair–Deficient Tumors https://t.co/tEWZq8etWv
nejm.org
Among patients with mismatch repair–deficient (dMMR), locally advanced rectal cancer, neoadjuvant checkpoint blockade eliminated the need for surgery in a high proportion of patients. Whether this ...
0
1
8
Now published in @JAMASurgery by @UrologyMSK @alvincgoh et al.: Surgical Performance Metrics for 1-Year Patient-Reported Outcomes After Radical Prostatectomy https://t.co/Df6hobZWsz
jamanetwork.com
This study attempts to develop surgical performance measures collected at the time of surgery that accurately predict future outcomes.
1
1
13
Now published in @UrolOncol by @UrologyMSK @SigridCarlsson, Joel Sheinfeld, @RichMatulewicz et al.: Convalescence after radical orchiectomy: Detailing surgical recovery with a novel electronic patient reported outcome (ePRO) platform https://t.co/qKk6EPY3EM
0
5
15
Now published in @Annals_Oncology by @UrologyMSK @RichMatulewicz, Brett Carver, Joel Sheinfeld et al.: Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors https://t.co/bQCqaDCZ0E
0
3
17
We are thrilled to share an incredible collaborative project to visualize nerves during surgery led by @bca_md and illuminarebio along with a host of incredible urology fellows over the past several years. https://t.co/FcOwswrong
jamanetwork.com
This nonrandomized clinical trial evaluates the use of rizedisben, a novel myelin-binding fluorophore, in minimally invasive surgery.
1
3
19
Now published in @JCOCCI_ASCO by @UrologyMSK @RichMatulewicz @SigridCarlsson @alvincgoh et al: Implementation of Recovery Tracker: A Postdischarge Electronic Remote Symptom-Monitoring Survey Tool After Major Urologic Oncology Surgeries https://t.co/ZkqiFUmotC
ascopubs.org
PURPOSERemote symptom monitoring shows promise in promoting postdischarge contact between patients and clinicians. Unique strategies may be needed to tailor reach and engagement to specific patient...
0
0
13
Now published in @JUrology by @UrologyMSK @RichMatulewicz et al: Updates to Microhematuria: AUA/SUFU Guideline (2025) https://t.co/YwsSH1KJyY
auajournals.org
Purpose:In 2023 the AUA in collaboration with the Society for Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) requested an Update Literature Review to incorporate new evidence...
0
0
6